PCAOB Deficiency Tracker
← Back to Explorer

Grant Thornton Bharat

India · Grant Thornton International Limited · Triennially Inspected

Inspection year
2025
Report date
23-Oct-2025
PCAOB release
104-2025-166
Audits reviewed
2
Audits w/ Part I.A deficiencies
2
Part I.A deficiency rate
100%
Part I.A deficiencies
3
Part I.B deficiencies
2
Report
View PDF ↗

Deficiencies (3)

Grouped by issuer and in the same order as the PCAOB report, so each item ties back directly to the source.

Issuer A2 deficiencies

#AreaDeficiencyStandardFlags
1RevenueThe firm selected for testing a control that consisted of the issuer's review of customer contracts for proper revenue recognition and identified a significant deficiency related to this control. The firm identified and tested a compensating control that it believed would mitigate the deficiency which consisted of another review control over customer contracts. The firm did not evaluate the review procedures that the control owner performed to be able to conclude that the compensating control mitigated the identified significant deficiency. (AS 2201.68)
Both financial statement and ICFR audits
AS 2201.68
Significant risk
2RevenueThe sample sizes the firm used in certain of its substantive procedures to test revenue were too small to provide sufficient appropriate audit evidence because the procedures were designed based on a level of control reliance that was not supported due to the deficiency in the firm's control testing discussed above. (AS 2301.16 .18 and .37; AS 2315.19. 23 and .23A)
Both financial statement and ICFR audits
AS 2301.16; AS 2301.18; AS 2301.37; AS 2315.19; AS 2315.23; AS 2315.23A
Significant risk

Issuer B1 deficiency

#AreaDeficiencyStandardFlags
1RevenueThe firm did not perform any procedures to evaluate the reliability of certain information used in its substantive testing of revenue. (AS 1105.04 and .06)
Financial statement audit only
AS 1105.4; AS 1105.6